| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
2',3'-Isopropylidene-isocytidine manufacturers
|
| | 2',3'-Isopropylidene-isocytidine Basic information |
| Product Name: | 2',3'-Isopropylidene-isocytidine | | Synonyms: | 2',3'-Isopropylidene-isocytidine;2',3'-Di-O-isopropylidene-isocytidine;2-Amino-1-[2,3-O-(1-methylethylidene)-beta-D-ribofuranosyl]-4(1H)-pyrimidinone;2',3'-O-Isopropylideneisocytidine;4(1H)-Pyrimidinone, 2-amino-1-[2,3-O-(1-methylethylidene)-β-D-ribofuranosyl]- | | CAS: | 5975-05-3 | | MF: | C12H17N3O5 | | MW: | 283.28 | | EINECS: | | | Product Categories: | | | Mol File: | 5975-05-3.mol |  |
| | 2',3'-Isopropylidene-isocytidine Chemical Properties |
| | 2',3'-Isopropylidene-isocytidine Usage And Synthesis |
| Uses | 2′,3′-O-Isopropylideneisocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2',3'-Isopropylidene-isocytidine Preparation Products And Raw materials |
|